This Verizon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Portfolio Pulse from Avi Kapoor
Several top Wall Street analysts have downgraded their ratings for major companies, including Verizon, Avery Dennison, Seres Therapeutics, ICON, and WillScot. These downgrades may impact the stock prices of these companies in the short term.
October 24, 2024 | 11:50 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
JP Morgan downgraded Avery Dennison from Overweight to Neutral and lowered the price target, indicating a less optimistic view.
The downgrade and lowered price target suggest a less optimistic view, which could negatively impact the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
Baird downgraded ICON from Outperform to Neutral with a $340 price target, indicating a more cautious stance.
The downgrade to Neutral suggests a more cautious stance, which may lead to a decrease in stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
JP Morgan downgraded Seres Therapeutics from Neutral to Underweight, potentially indicating a negative outlook.
The downgrade from Neutral to Underweight by JP Morgan suggests a negative outlook, which could lead to a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Keybanc downgraded Verizon from Overweight to Sector Weight, indicating a less favorable view.
The downgrade to Sector Weight suggests a less favorable view, which could negatively impact the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Baird downgraded WillScot from Outperform to Neutral, maintaining a $42 price target, indicating a neutral outlook.
The downgrade to Neutral with a maintained price target suggests a neutral outlook, likely resulting in minimal short-term price impact.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 80